Last reviewed · How we verify
administration of vitamin C — Competitive Intelligence Brief
phase 3
Vitamin / Antioxidant
Critical Care / Infectious Disease / General Health
Small molecule
Live · refreshed every 30 min
Target snapshot
administration of vitamin C (administration of vitamin C) — Meir Medical Center. Vitamin C acts as an antioxidant and cofactor for enzymatic reactions, reducing oxidative stress and supporting immune function.
Comparator set (2 drugs)
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| administration of vitamin C TARGET | administration of vitamin C | Meir Medical Center | phase 3 | Vitamin / Antioxidant | ||
| vitamin c 20% | vitamin c 20% | Kasr El Aini Hospital | marketed | Vitamin / Antioxidant / Micronutrient | ||
| Placebo - ascorbic acid | Placebo - ascorbic acid | St. Joseph's Hospital and Medical Center, Phoenix | phase 3 | Vitamin / Antioxidant |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape (Vitamin / Antioxidant class)
- Meir Medical Center · 1 drug in this class
- St. Joseph's Hospital and Medical Center, Phoenix · 1 drug in this class
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- administration of vitamin C CI watch — RSS
- administration of vitamin C CI watch — Atom
- administration of vitamin C CI watch — JSON
- administration of vitamin C alone — RSS
- Whole Vitamin / Antioxidant class — RSS
Cite this brief
Drug Landscape (2026). administration of vitamin C — Competitive Intelligence Brief. https://druglandscape.com/ci/administration-of-vitamin-c. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab